InvestorsHub Logo
Post# of 252009
Next 10
Followers 9
Posts 1005
Boards Moderated 0
Alias Born 02/23/2010

Re: None

Friday, 08/04/2023 11:20:15 AM

Friday, August 04, 2023 11:20:15 AM

Post# of 252009
RVNC 'annecdata'

Had a minute to talk to my Neuro about Daxi. Not a lot to read into it other than the CD launch may be slower than most are anticipating, even some expecting a slow launch.

He is part of a large Neuro group. Everyone injects BoTN, including the PA's. He has treated with Botox for a long time, participated as an investigator in migraine trials leading to approval in that indication, and trains injectors on a regular basis. He has quite a few CD patients. This group does research studies. RVNC had a trial site in the metro but this group did not participate.

Name awareness of Daxi = none
Awarness of a new BoTN for CD = none
Awarness of duration profile = none

Additional comments:
First priority is if something is working for a patient, don't change it.
He does use BoTN other than Botox if that patient needs it but he is averse to using different unit amounts and so on.
While he did not have specific Daxi duration info (not my place to do that) his comments in general on increased durability showed indifference. It isn't clear if a 2x difference would change anything but the hypothetical he assumed wouldn't change his practice.

As far as speculating on him being a 'Botox man' or anything similar, my advice is don't. There is nothing to read into anything beyond what I wrote. This doctor and this group is patient first, that is why I use them. They are top-notch.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.